These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 10970260

  • 1. Stargardt's macular dystrophy--a patient's perspective.
    Miedziak AI, Perski T, Andrews PP, Donoso LA.
    Optometry; 2000 Mar; 71(3):165-76. PubMed ID: 10970260
    [Abstract] [Full Text] [Related]

  • 2. Visual rehabilitation of patients with Stargardt's disease.
    Shah M, Zaman M, Khan MT, Khan MD.
    J Coll Physicians Surg Pak; 2008 May; 18(5):294-8. PubMed ID: 18541085
    [Abstract] [Full Text] [Related]

  • 3. Comparison of visual acuity loss in patients with different stages of Stargardt's disease.
    Kim LS, Fishman GA.
    Ophthalmology; 2006 Oct; 113(10):1748-51. PubMed ID: 16872677
    [Abstract] [Full Text] [Related]

  • 4. [Stargardt's disease and its intrafamilial variability].
    Lansel N, Niemeyer G, Thölen A.
    Klin Monbl Augenheilkd; 2000 May; 216(5):342-5. PubMed ID: 10863711
    [Abstract] [Full Text] [Related]

  • 5. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT, Banks AD, Stinnett SS, Toth CA.
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [Abstract] [Full Text] [Related]

  • 6. [Optical coherence tomography in Stargardt's dystrophy].
    Samsel A, Dróbecka-Brydak E, Brydak-Godowska J, Ciszewska J, Kecik D.
    Klin Oczna; 2005 Jan; 107(10-12):668-71. PubMed ID: 16619816
    [Abstract] [Full Text] [Related]

  • 7. Assessment of central visual function in Stargardt's disease/fundus flavimaculatus with ultrahigh-resolution optical coherence tomography.
    Ergun E, Hermann B, Wirtitsch M, Unterhuber A, Ko TH, Sattmann H, Scholda C, Fujimoto JG, Stur M, Drexler W.
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):310-6. PubMed ID: 15623790
    [Abstract] [Full Text] [Related]

  • 8. Dominant inheritance of Stargardt's disease.
    Bither PP, Berns LA.
    J Am Optom Assoc; 1988 Feb; 59(2):112-7. PubMed ID: 3361050
    [Abstract] [Full Text] [Related]

  • 9. Validation of the Daily Living Tasks Dependent on Vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration.
    Schmier JK, Halpern MT, Covert D.
    Ophthalmic Epidemiol; 2006 Apr; 13(2):137-43. PubMed ID: 16581618
    [Abstract] [Full Text] [Related]

  • 10. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA, Submacular Surgery Trials Research Group.
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [Abstract] [Full Text] [Related]

  • 11. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results.
    Hudson HL, Lane SS, Heier JS, Stulting RD, Singerman L, Lichter PR, Sternberg P, Chang DF, IMT-002 Study Group.
    Ophthalmology; 2006 Nov; 113(11):1987-2001. PubMed ID: 16989902
    [Abstract] [Full Text] [Related]

  • 12. In vivo measurement of lipofuscin in Stargardt's disease--Fundus flavimaculatus.
    Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ.
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2327-31. PubMed ID: 7558729
    [Abstract] [Full Text] [Related]

  • 13. Reading performance with low-vision aids and vision-related quality of life after macular translocation surgery in patients with age-related macular degeneration.
    Nguyen NX, Besch D, Bartz-Schmidt K, Gelisken F, Trauzettel-Klosinski S.
    Acta Ophthalmol Scand; 2007 Dec; 85(8):877-82. PubMed ID: 17651462
    [Abstract] [Full Text] [Related]

  • 14. Assessing participation in daily living and the effectiveness of rehabiliation in age related macular degeneration patients using the impact of vision impairment scale.
    Lamoureux EL, Pallant JF, Pesudovs K, Tennant A, Rees G, O'Connor PM, Keeffe JE.
    Ophthalmic Epidemiol; 2008 Dec; 15(2):105-13. PubMed ID: 18432494
    [Abstract] [Full Text] [Related]

  • 15. Isotretinoin treatment inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.
    Radu RA, Mata NL, Nusinowitz S, Liu X, Travis GH.
    Novartis Found Symp; 2004 Dec; 255():51-63; discussion 63-7, 177-8. PubMed ID: 14750596
    [Abstract] [Full Text] [Related]

  • 16. [Visual function and quality of life in patients with age-related maculopathy: results of the Münster Age and Retina Study (MARS)].
    Fuhs A, Dasch B, Behrens T, Meister A, Krause K, Pauleikhoff D, Hense HW.
    Klin Monbl Augenheilkd; 2005 Aug; 222(8):649-54. PubMed ID: 16118746
    [Abstract] [Full Text] [Related]

  • 17. Low-vision aids in Stargardt's disease.
    Schwartzenberg T, Merin S, Nawratzki I, Yanko L.
    Ann Ophthalmol; 1988 Nov; 20(11):428-30. PubMed ID: 3266066
    [Abstract] [Full Text] [Related]

  • 18. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH, Nordmann JP, Colin E, Arnould B.
    Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
    [Abstract] [Full Text] [Related]

  • 19. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration.
    Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA.
    Ophthalmology; 2005 Jan; 112(1):144-51. PubMed ID: 15629835
    [Abstract] [Full Text] [Related]

  • 20. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease.
    Rotenstreich Y, Fishman GA, Anderson RJ.
    Ophthalmology; 2003 Jun; 110(6):1151-8. PubMed ID: 12799240
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.